These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 22842602)

  • 1. Species level identification and antifungal susceptibility of yeasts isolated from various clinical specimens and evaluation of Integral System Yeasts Plus.
    Bicmen C; Doluca M; Gulat S; Gunduz AT; Tuksavul F
    New Microbiol; 2012 Jul; 35(3):327-34. PubMed ID: 22842602
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antifungal susceptibility of bloodstream yeasts isolated at a public children's hospital in Brazil: comparison of the Etest and the AFST-EUCAST microdilution method.
    Matsumoto FE; Dias AL; Melhem MS; Szeszs MW; Auler ME; Ruiz LS; Gonçalves da Silva E; Gandra RF; Paula CR
    Can J Microbiol; 2007 Dec; 53(12):1300-6. PubMed ID: 18059562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of possibilities in identification and susceptibility testing for Candida glabrata clinical isolates with the Integral System Yeast Plus (ISYP).
    Szweda P; Gucwa K; Naumiuk L; Romanowska E; Dzierzanowska-Fangrat K; Brillowska-Dabrowska A; Wojciechowska-Koszko I; Milewski S
    Acta Microbiol Immunol Hung; 2014 Jun; 61(2):161-72. PubMed ID: 24939684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral Candida isolates among HIV-infected subjects in Nigeria.
    Nweze EI; Ogbonnaya UL
    J Microbiol Immunol Infect; 2011 Jun; 44(3):172-7. PubMed ID: 21524610
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Multisite evaluation of a colorimetric broth microdilution antifungal susceptibility testing].
    Yamane N; Igari J
    Rinsho Byori; 1997 Feb; 45(2):190-9. PubMed ID: 9121005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. National surveillance of species distribution in blood isolates of Candida species in Japan and their susceptibility to six antifungal agents including voriconazole and micafungin.
    Takakura S; Fujihara N; Saito T; Kudo T; Iinuma Y; Ichiyama S
    J Antimicrob Chemother; 2004 Feb; 53(2):283-9. PubMed ID: 14688039
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activity of voriconazole, itraconazole, fluconazole and amphotericin B in vitro against 1763 yeasts from 472 patients in the voriconazole phase III clinical studies.
    Johnson E; Espinel-Ingroff A; Szekely A; Hockey H; Troke P
    Int J Antimicrob Agents; 2008 Dec; 32(6):511-4. PubMed ID: 18790613
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Comparison of broth microdilution and E-test methods for the antifungal susceptibility testing of Candida spp. strains isolated from blood cultures].
    Ozcan SK; Mutlu B; Dündar D; Willke A
    Mikrobiyol Bul; 2010 Apr; 44(2):263-71. PubMed ID: 20549961
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Results from the ARTEMIS DISK Global Antifungal Surveillance study, 1997 to 2005: an 8.5-year analysis of susceptibilities of Candida species and other yeast species to fluconazole and voriconazole determined by CLSI standardized disk diffusion testing.
    Pfaller MA; Diekema DJ; Gibbs DL; Newell VA; Meis JF; Gould IM; Fu W; Colombo AL; Rodriguez-Noriega E;
    J Clin Microbiol; 2007 Jun; 45(6):1735-45. PubMed ID: 17442797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multicenter comparison of the sensititre YeastOne Colorimetric Antifungal Panel with the National Committee for Clinical Laboratory standards M27-A reference method for testing clinical isolates of common and emerging Candida spp., Cryptococcus spp., and other yeasts and yeast-like organisms.
    Espinel-Ingroff A; Pfaller M; Messer SA; Knapp CC; Killian S; Norris HA; Ghannoum MA
    J Clin Microbiol; 1999 Mar; 37(3):591-5. PubMed ID: 9986817
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Direct antifungal susceptibility testing of positive Candida blood cultures by sensititre YeastOne.
    Avolio M; Grosso S; Bruschetta G; De Rosa R; Camporese A
    New Microbiol; 2009 Apr; 32(2):179-84. PubMed ID: 19579696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of antifungal MICs for yeasts obtained using the EUCAST method in a reference laboratory and the Etest in nine different hospital laboratories.
    Dannaoui E; Paugam A; Develoux M; Chochillon C; Matheron J; Datry A; Bouges-Michel C; Bonnal C; Dromer F; Bretagne S
    Clin Microbiol Infect; 2010 Jul; 16(7):863-9. PubMed ID: 19778296
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Species distribution, antifungal susceptibility and clonal relatedness of Candida isolates from patients in neonatal and pediatric intensive care units at a medical center in Turkey.
    Kuzucu C; Durmaz R; Otlu B; Aktas E; Gulcan H; Cizmeci Z
    New Microbiol; 2008 Jul; 31(3):401-8. PubMed ID: 18843896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative evaluation of Sensititre YeastOne vs. the NCCLS M27A protocol and E-test for antifungal susceptibility testing of yeasts.
    Lombardi G; Farina C; Andreoni S; Fazii P; Faggi E; Pini G; Manso E; Nanetti A; Mazzoni A
    Mycoses; 2004 Oct; 47(9-10):397-401. PubMed ID: 15504123
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative evaluation of macrodilution and alamar colorimetric microdilution broth methods for antifungal susceptibility testing of yeast isolates.
    To WK; Fothergill AW; Rinaldi MG
    J Clin Microbiol; 1995 Oct; 33(10):2660-4. PubMed ID: 8567901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro susceptibility of oral Candida to seven antifungal agents.
    Kuriyama T; Williams DW; Bagg J; Coulter WA; Ready D; Lewis MA
    Oral Microbiol Immunol; 2005 Dec; 20(6):349-53. PubMed ID: 16238594
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Evaluation of three methods for in vitro detection of antifungal susceptibility of Candida species].
    Maldonado I; Fernández Canigia L; Vivot W; Domecq P; Davel G; Córdoba S
    Rev Argent Microbiol; 2011; 43(2):120-6. PubMed ID: 21731975
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro susceptibility of Candida species to five antifungal agents in a German university hospital assessed by the reference broth microdilution method and Etest.
    Fleck R; Dietz A; Hof H
    J Antimicrob Chemother; 2007 Apr; 59(4):767-71. PubMed ID: 17293369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro susceptibility testing of Candida and Aspergillus spp. to voriconazole and other antifungal agents using Etest: results of a French multicentre study.
    Mallié M; Bastide JM; Blancard A; Bonnin A; Bretagne S; Cambon M; Chandenier J; Chauveau V; Couprie B; Datry A; Feuilhade M; Grillot R; Guiguen C; Lavarde V; Letscher V; Linas MD; Michel A; Morin O; Paugam A; Piens MA; Raberin H; Tissot E; Toubas D; Wade A
    Int J Antimicrob Agents; 2005 Apr; 25(4):321-8. PubMed ID: 15784312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the Sensititre YeastOne colorimetric microdilution panel and the NCCLS broth microdilution method for antifungal susceptibility testing against Candida species.
    Bernal S; Aller AI; Chávez M; Valverde A; Serrano C; Gutiérrez MJ; Quindós G; Martín Mazuelos E
    Chemotherapy; 2002 Mar; 48(1):21-5. PubMed ID: 11901252
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.